FTSE struggles to move despite gains for drugs firms

Trading is looking strong for some of the pharmaceutical firms this morning, but the FTSE 100 is struggling to make the best of it so far thanks to Barclays. The benchmark FTSE 100 is down just a fraction at 3926, having climbed made its biggest monthly gain since in April and risen 8.7%. Barclays has already lost 2.4% to 432.25p while Lloyds TSB Group, has dropped 2.4% to 411.5p. At the other end of the spectrum, Amersham, which makes medical tools, has climbed 27.75p or 6.6% to 449.25p as first quarter is little changed on last year's £381m. AstraZeneca is also up 79p...